Skip to main content
Risankizumab shows efficacy, tolerability in patients with PsA
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Risankizumab shows efficacy, tolerability in patients with PsA
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
0.89
Biologic Therapy
0
0.88
Fatigue
0
0.58
Psoriasis
0
0.47
Arthritis
0
0.44
Grant
0
0.29
Hospital
0
0.29
Uveitis
0
0.25
Biomarker
0
0.15
Cancer
0
0.15
Chronic Disease
0
0.15
Cytokines
0
0.15
Dermatoses
0
0.15
Disability
0
0.15
Europe
0
0.15
Glucocorticoid
0
0.15
Immunoglobulin A (IgA)
0
0.15
Interleukin
0
0.15
Monoclonal Antibody
0
0.15
Phototherapy
0
0.15
Plaque Psoriasis
0
0.15
Refractory
0
0.15
Inflammatory Bowel Disease
0
0.1
Specialty
Lead
score
Rheumatology
1
1
Dermatology
0
0.9
Internal Medicine
0
0.7
Pharmacist
0
0.67
Hematology-Oncology
0
0.45
Hospital Medicine
0
0.42
Orthopaedics
0
0.37
Ophthalmology
0
0.31
Nursing
0
0.27
Gastroenterology
0
0.17
Allergy & Clinical Immunology
0
0.16
Edit Tags